AGENDA | JULY 16, 2020

1:00 - 1:05 PM

Welcome and Introduction to OIS

Presented By:
Bill Link, PhD, Managing Partner - Flying L Partners

1:05 - 1:20 PM

Overview of the Healthcare Public Market

Presented By:
Udit Patel, Executive Director, Healthcare Investment Banking - Piper Sandler

1:20 - 1:30 PM

OIS Index Performance

Presented By:
Michael Lachman, President - EyeQ Research

1:30 - 2:20 PM

Company Showcase

1:30- 1:40 PM | Oyster Point Pharma | Jeffrey Nau, PhD, President & CEO
1:40 - 1:50 PM | Aldeyra Therapeutics | Todd Brady, MD, PhD, CEO, President & Director
1:50 - 2:00 PM | Eyenovia | Michael Rowe, Corporate Vice President
2:00 - 2:10 PM | Ocular Therapeutix | Antony Mattessich, President & CEO
2:10 - 2:20 PM | EyePoint Pharmaceuticals | Jay Duker, MD, Chief Strategic Scientific Officer

1:30 - 2:20 PM

The Ophthalmology Outlook Panel

A panel discussion amongst the presenters will dig deeper into the outlook and potential impact of their therapies as they hit the market.

Panelists:
Todd Brady, MD, PhD, CEO, President & Director - Aldeyra Therapeutics
Jay Duker, MD, Chief Strategic Scientific Officer - EyePoint Pharmaceuticals
Antony Mattessich, President & CEO - Ocular Therapeutix
Jeffrey Nau, PhD, President & CEO - Oyster Point Pharma
Michael Rowe, Corporate Vice President - Eyenovia

Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Senior Managing Director - Blackstone Life Sciences